The blockade of PD-L1 via anti-PD-L1 antibody or MEK inhibitor restored the attenuated antitumor immunity, resulting in an enhanced tumor suppression both in vitro co-culture and in vivo animal models. This evidence concerns the gene MAP2K7 and neoplasm.